Visiongain pharma report catalogue ei

on

  • 638 views

If you would like more information on any of our reports please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website http://www.visiongain.com/Sector/8/Pharma

If you would like more information on any of our reports please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website http://www.visiongain.com/Sector/8/Pharma

Statistics

Views

Total Views
638
Views on SlideShare
638
Embed Views
0

Actions

Likes
0
Downloads
99
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Visiongain pharma report catalogue ei Visiongain pharma report catalogue ei Presentation Transcript

    • CLICK ON REPORT TITLE TO VIEW MORE DETAILS • Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021 Published 06 May 2011 • Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023 Published 17 June 2013 • Antibacterial Drugs: World Market Prospects 2013-2023 Published 21 March 2013 • Antithrombotic Drugs: World Market 2013-2023 Published 14 February 2013 • Asthma and COPD Therapies World Market 2013-2023 Published 06 September 2013 • Biobanking for Medicine: Technology and Market 2013-2023 Published 18 March 2013 • Biomarkers: Technological and Commercial Outlook 2013-2023 Published 23 July 2013 • Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023 Published 10 April 2013 • Biosimilars and Follow-On Biologics: World Market 2013-2023 Published 30 April 2013 • Chinese Pharmaceutical Market 2013-2023 Published 09 April 2013 • Dermatological Drugs: World Market Prospects 2013-2023 Published 05 March 2013 • Diabetes Treatments: World Drug Market 2013-2023 Published 24 April 2013 • Drug Discovery Outsourcing: World Market 2013-2023 Published 30 November 2012 • Epigenetic Therapies and Technologies: World Market Prospects 2013-2023 Published 09 January 2011 • Generic Drugs: World Market Outlook 2013-2023 Published 13 November 2012 • Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021 Published 03 May 2011 • Hepatitis Drugs and Vaccines: World Market 2013-2023 Published 21 June 2013 • Inflammatory Bowel Diseases: World Drug Market 2013-2023 Published 17 July 2013 • Leading Anti-Cancer Drugs and Associated Market 2013-2023 Published 11 June 2013 • Leading Anti-Cancer Drugs: World Market Prospects 2011-2021 Published 25 February 2011
    • • Lyophilisation for Pharmaceuticals: Products and Services Market 2012-2022 Published 13 August 2012 • Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 Published 27 June 2011 • Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2013-2023 Published 01 November 2012 • Multiple Sclerosis Treatment: World Drug Market 2012-2022 Published 23 November 2011 • Neuroprotective Products: World Market Prospects 2012-2022 Published 10 May 2012 • Pharma Clinical Trial Services: World Market 2013-2023 Published 25 January 2013 • Pharma Contract Manufacturing: World Market Outlook 2013-2023 Published 11 September 2013 • Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022 Published 21 June 2012 • Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022 Published 10 September 2012 • Pharma Leader Series: Top 20 Ophthalmic Drug Manufacturers 2012-2022 Published 16 October 2012 • Next-Generation Antibody Therapeutics Market 2013-2023 • Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2013-2023 • Next-Generation Antibody Therapies: Pipeline and Market 2011-2021 • Pharma Leader Series: Top 50 Generic Drug Manufacturers 2013-2023 Published 05 February 2013 Published 08 November 2011 • Ophthalmic Drugs: World Market Prospects 2013-2023 Published 27 March 2013 • Orphan Drugs for Cancer: R&D and Market 2013-2023 Published 29 July 2013 • Parkinson’s Disease: World Drug Market 2013-2023 Published 02 January 2013 Published 19 September 2013 Published 04 July 2013 • Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023 Published 01 July 2013 • Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022 Published 15 February 2012
    • • Pharma Wholesale and Distribution Market: World Outlook 2013-2023 Published 03 June 2013 • Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2012-2022 Published 26 October 2012 • Pharmaceutical Contract Manufacturing: World Market Outlook 2012-2022 Published 20 August 2012 • Pharmaceutical Wholesale and Distribution Industry: World Outlook 2011-2021 Published 01 April 2011 • Pharmacovigilance and Related Developments 2011-2021 Published 22 August 2011 • Psoriasis Treatment: World Drug Market 2013-2023 Published 05 September 2013 • Rheumatoid Arthritis (RA): World Drug Market 2013-2023 Published 19 April 2013 • RNAi for Therapeutic Applications Market Prospects 2011-2021 Published 29 March 2011 • Single-Use Bioreactors for Pharma: World Market 2013-2023 Published 03 June 2013 • Small-Molecule Targeted Cancer Therapies: World Market 2013-2023 Published 10 December 2011 • Smoking Cessation Drugs: World Market Prospects 2012-2022 Published 16 April 2012 • Statins: World Market Outlook 2011-2021 Published 03 March 2011 • Stem Cell Technologies: World Market Outlook 2013-2023 Published 02 August 2013 • The Prostate Cancer Therapeutics Market 2013-2023 Published 17 September 2013 • Therapeutic Monoclonal Antibodies: World Market 2011-2021 Published 19 September 2011 • Translational Regenerative Medicine: Market Prospects 2012-2022 Published 31 August 2012 • Vaccine Manufacturing Technology and Services: World Market 2013-2023 Published 16 January 2013 • World Anti-Obesity Drug Market 2011-2021 Published 21 February 2011 • World Biological Drugs Market 2013-2023 Published 13 May 2013 • World Diabetes Drug Market 2011-2021 Published 11 March 2011
    • • World Influenza Vaccines Market 2011-2021 Published 07 February 2011 • World Mobile Healthcare (mHealth) Market 2013-2018: eHealth, Telemedicine & Health informatics Published 29 April 2013 • World Multiple Myeloma Drug Treatment Market 2012-2022 Published 17 September 2012 • World OTC Pharmaceutical Market 2012-2022 Published 06 June 2012 • World Pain Relieving Drug Market 2013-2023 Published 24 July 2013 • World Pharma Contract Sales Organisation (CSO) Market 2011-2021 Published 30 September 2011 • World Pharmaceutical Contract Sales Market 2013-2023 Published 06 November 2012 • World Vaccines Market 2012-2022 Published 25 July 2012
    • Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2013-2023 What does the future hold for makers of biosimilar drugs? Visiongain’s updated report shows you those companies’ prospects to 2023. There you see results, trends, opportunities, and revenue predictions. Our study analyses 25 leading developers, producers and marketers of biosimilars, also with discussion of other companies. There you find information on established and rising organisations. Discover their sales potentials. Published 19 September 2013 http://www.visiongain.com/Report/1114/Pharma-Leader-Series-Top-25-Biosimilar-DrugManufacturers-2013-2023 The Prostate Cancer Therapeutics Market 2013-2023 How are the leading segments in the prostate cancer therapeutics market performing? Visiongain’s new report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions. Our study lets you assess leading drugs and devices in the prostate cancer therapeutics market, showing their prospects to 2023. There you see financial results, interviews, trends, opportunities, and revenue predictions. You will also find information on pipeline drugs in the market. Published 17 September 2013 http://www.visiongain.com/Report/1111/The-Prostate-Cancer-Therapeutics-Market-2013-2023
    • Pharma Contract Manufacturing: World Market Outlook 2013-2023 Where’s outsourced pharma manufacturing heading? Visiongain’s updated report predicts that industry’s revenues from 2013. There you find potentials for sales growth, also understanding trends, technologies for drugs, clients’ needs, and opportunities. That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. Avoid falling behind, then. Instead see what’s happening for those medical contracting services - outsourcing and off-shoring - finding how you can gain. Published 11 September 2013 http://www.visiongain.com/Report/1110/Pharma-Contract-Manufacturing-World-MarketOutlook-2013-2023 Asthma and COPD Therapies: World Market 2013-2023 See what the future holds for asthma and COPD therapies. Visiongain’s report gives you drug revenue predictions to 2023. You find data, trends, opportunities and commercial prospects. That new study lets you assess forecasted sales at overall world market, submarket, product, company and national level. You see why the asthma and COPD market will grow, as we predict. Published 06 September 2013 http://www.visiongain.com/Report/1109/Asthma-and-COPD-Therapies-World-Market-2013-2023
    • Psoriasis Treatment: World Drug Market 2013-2023 What’s the future of treating psoriasis? Visiongain’s new report gives you revenue predictions from 2013, helping you stay ahead. There you see financial results, R&D trends, opportunities, and potential revenues. Avoid falling behind, then, missing business or losing influence. In our new report you see forecasted sales to 2023 at overall world market, submarket, product, and national level. You also assess technologies, competitive forces and expected products. Read on to explore that industry and see what its future market could be worth. Published 05 August 2013 http://www.visiongain.com/Report/1108/Psoriasis-Treatment-World-Drug-Market-2013-2023 Stem Cell Technologies: World Market Outlook 2013-2023 What are the commercial prospects for stem cells? Visiongain’s updated report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends, technologies, therapies, and opportunities. That study gives you revenue forecasts to 2023 for the overall world market and its submarkets. See what’s happening for those cellular technologies, finding how you can gain. Published 02 August 2013 http://www.visiongain.com/Report/1092/Stem-Cell-Technologies-World-Market-Outlook-2013-2023
    • Orphan Drugs for Cancer: R&D and Market 2013-2023 What’s the future of orphan medicines to treat cancers? Visiongain’s new report gives you revenue predictions from 2013. There you explore results, R&D, opportunities, and potential sales. Orphan drugs can be profitable. In our analysis you see forecasted sales to 2023 at overall world market, submarket, product, and national level. You see the potential of treatments for rare cancers. Try our report now, helping you stay ahead. Published 29 July 2013 http://www.visiongain.com/Report/1090/Orphan-Drugs-for-Cancer-R-D-and-Market-2013-2023 World Pain Relieving Drug Market 2013-2023 See what the future holds for painkillers. Visiongain’s report gives you revenue predictions to 2023. You find data, trends, opportunities and commercial prospects. That new study lets you assess forecasted sales at overall world market, submarket, product and national level. You see why the pain relievers industry and market will grow, as we predict. Published 24 July 2013 http://www.visiongain.com/Report/1088/World-Pain-Relieving-Drug-Market-2013-2023
    • Biomarkers: Technological and Commercial Outlook 2013-2023 What’s the outlook for biomarkers? Visiongain’s updated report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends and opportunities. That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. See what’s happening for those technologies, finding how you can gain. Published 23 July 2013 http://www.visiongain.com/Report/1086/Biomarkers-Technological-and-Commercial-Outlook-2013-2023 Inflammatory Bowel Diseases: World Drug Market 2013-2023 What’s the future for treating inflammatory bowel diseases (IBD)? Visiongain’s updated report gives you revenue predictions from 2013, helping you stay ahead. There you find financial results, R&D trends, opportunities, and potential revenues. In that work you see forecasted sales to 2023 at overall world market, submarket, product, and national level. You also assess emerging technologies. Published 18 July 2013 http://www.visiongain.com/Report/1084/Inflammatory-Bowel-Diseases-World-Drug-Market-2013-2023
    • Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023 What does the future hold for biosimilar therapeutic antibodies? Visiongain’s new report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends and opportunities. In that study you get revenue forecasts at overall world market, submarket, product, and national level. See what’s happening for those technologies, finding how you can gain. Published 10 July 2013 http://www.visiongain.com/Report/1080/Biosimilar-Monoclonal-Antibodies-World-MarketProspects-2013-2023 Pharma Leader Series: Top 50 Generic Drug Manufacturers 2013-2023 What does the future hold for makers of generic drugs? Visiongain’s updated report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions. Our study analyses 50 leading generics producers and marketers. There you find information on established and rising companies. Discover their sales potentials. Published 04 July 2013 http://www.visiongain.com/Report/1079/Pharma-Leader-Series-Top-50-Generic-DrugManufacturers-2013-2023
    • Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023 How are pharma contract manufacturing organisations (CMOs) performing? Visiongain’s new report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions. Our study analyses 30 leading CMOs. There you discover how revenues from drug production services can increase. That way you find information you need on established and emerging companies. Published 01 July 2013 http://www.visiongain.com/Report/1076/Pharma-Leader-Series-Top-Pharma-Contract-ManufacturingOrganisations-(CMOs)-2013-2023 Hepatitis Drugs and Vaccines: World Market 2013-2023 Where are hepatitis medicines going? Visiongain’s updated report predicts revenues there from 2013 to 2023. It also explains trends in that business and technology - with prospects and opportunities - to help your work. In that study you gain sales forecasts at overall world market, submarket, product, and national level. See what’s happening. Also discover what has most growth potential. Published 21 June 2013 http://www.visiongain.com/Report/1071/Hepatitis-Drugs-and-Vaccines-World-Market-2013-2023
    • Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023 Where’s treatment of Alzheimer’s disease heading? Visiongain’s new report gives you revenue predictions for those drugs and diagnostic tests from 2013, helping you stay ahead. There you find financial data, R&D trends, opportunities, and prospects. In particular, you see forecasted sales to 2023 at overall world market, submarket, product, and national level. Published 17 June 2013 http://www.visiongain.com/Report/1068/Alzheimer’s-Disease-Therapeutics-and-Diagnostics-WorldMarket-2013-2023 Leading Anti-Cancer Drugs and Associated Market 2013-2023 Do you want to assess the future of cancer medicines? Visiongain’s updated report gives you revenue predictions there from 2013, helping you stay ahead. You find financial data, R&D trends, opportunities, and outlooks. In that work you see forecasted sales to 2023 at overall world market, submarket, product, and national level. You also assess emerging trends, technologies, and expected drugs. Published 11 June 2013 http://www.visiongain.com/Report/1063/Leading-Anti-Cancer-Drugs-and-Associated-Market-2013-2023
    • Single-Use Bioreactors for Pharma: World Market 2013-2023 Where’s the single-use bioreactors market heading? How are these products performing? Visiongain’s updated report gives you forecasted revenues there to 2023 and also explains R&D trends, outlooks and commercial opportunities. Our study lets you assess sales data and predictions for the world single-use bioreactors market, submarkets, important products and national markets. Those analyses show you that pharmaceutical field’s most promising and lucrative segments. Published 03 June 2013 http://www.visiongain.com/Report/1057/Single-Use-Bioreactors-for-Pharma-World-Market-2013-2023 Pharma Wholesale and Distribution Market: World Outlook 2013-2023 Where’s the drug wholesaling and distribution market heading? Visiongain’s updated report predicts revenues there from 2013 to 2023. It also explains trends in business and technology, prospects, and opportunities to help your work. In that study you gain sales forecasts at overall world market, submarket, company, and national level. Published 03 June 2013 http://www.visiongain.com/Report/1056/Pharma-Wholesale-and-Distribution-Market-WorldOutlook-2013-2023
    • World Biological Drugs Market 2013-2023 Do you want to find sales potentials of biological drugs? Visiongain’s updated report gives you revenue predictions for biologics from 2013, helping you stay ahead. There you find financial data, R&D trends, opportunities, and discussions of prospects. In that work you see forecasted sales to 2023 at overall world market, submarket, product, and national level. You also assess emerging trends, technologies, and expected products. Published 13 May 2013 http://www.visiongain.com/Report/1048/World-Biological-Drugs-Market-2013-2023 Biosimilars and Follow-On Biologics: World Market 2013-2023 Do you want to find the sales potential of biosimilars? visiongain’s updated report gives you revenue predictions for those biological drugs from 2013, helping you stay ahead. There you find financial data, R&D trends, opportunities and discussions of prospects. In that work you see forecasted sales to 2023 at overall world market, submarket, molecule and national level. You also assess emerging trends, technologies and expected products. Published 30 April 2013 https://www.visiongain.com/Report/1039/Biosimilars-And-Follow-On-Biologics-World-Market-2013-2023
    • World Mobile Healthcare (mHealth) Market 2013-2018: eHealth, Telemedicine & Health informatics The recent explosion in mobile communications has been driven by increased uptake of devices such as the smartphone and tablet. Synonymous with these devices are app stores which offer a huge array of downloadable programs and services, many of which apply to the healthcare field. As 4G and LTE promise to transform bandwidth , we expect the usage of mobile devices to expand to encompass many fields, especially that of healthcare. Visiongain has determined that the value of the global mHealth market in 2013 will reach $2bn. Published 29 April 2013 https://www.visiongain.com/Report/1038/World-Mobile-Healthcare-(mHealth)-Market-2013-2018 Diabetes Treatments: World Drug Market 2013-2023 Where’s the diabetic treatments market heading? How are those products performing? visiongain’s updated report gives you forecasted revenues there to 2023 and also explains R&D trends, outlooks and commercial opportunities. Our study lets you assess sales data and predictions for the world antidiabetic medicines market, therapeutic submarkets, products and national markets. Those analyses show you that pharmaceutical field’s most promising and lucrative segments. Established and emerging diabetes-treating drugs have potential. Read on to scan features of their industry, find what drives it, and see what its future market could be worth. Published 24 April 2013 https://www.visiongain.com/Report/1033/Diabetes-Treatments-World-Drug-Market-2013-2023
    • Rheumatoid Arthritis (RA): World Drug Market 2013-2023 Where’s the arthritic treatment market heading? Visiongain’s updated report gives you forecasted revenues to 2023 for drugs treating human rheumatoid arthritis (RA). There you find R&D trends, outlooks and commercial opportunities. Our study lets you assess sales data and predictions for the world RA medicines market, therapeutic submarkets, products and national markets. Those analyses show you that pharmaceutical field’s most promising and lucrative segments. Established and emerging anti-rheumatic technologies have potential. Read on to scan features of that industry, find what drives it, and see what its future market could be worth. Published 19 April 2013 https://www.visiongain.com/Report/1029/Rheumatoid-Arthritis-(RA)-World-Drug-Market-2013-2023 Chinese Pharmaceutical Market 2013-2023 What’s the outlook for the Chinese pharma market? Can it sustain high growth? Visiongain’s updated report gives you forecasted revenues there to 2023. That work also explains medical and technological trends, prospects and commercial opportunities. Our study lets you assess sales data and detailed predictions. There, you investigate activities of domestic and international companies and assess their environment. That analysis shows you Chinese pharma’s most promising and lucrative areas. China still holds great potential for medical sales. Read on to scan crucial features of that market, find what drives it, and see what its future could be worth to healthcare industries. Published 09 April 2013 https://www.visiongain.com/Report/1018/Chinese-Pharmaceutical-Market-2013-2023
    • Ophthalmic Drugs: World Market Prospects 2013-2023 What are the commercial prospects for treating eye disorders? Visiongain’s new report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for ocular drugs. Our study lets you assess sales data at overall world market, submarket and national level. There you find that industry’s most promising and lucrative segments, helping your research and analyses. Published 27 March 2013 http://www.visiongain.com/Report/1012/Ophthalmic-Drugs-World-Market-Prospects-2013-2023 Antibacterial Drugs: World Market Prospects 2013-2023 Where’s the antibiotics market heading? How are those products performing? Visiongain’s updated report gives you forecasted revenues there to 2023 and also explains R&D trends, outlooks and commercial opportunities. Our study lets you assess sales data and predictions for the world antibacterial drugs market, therapeutic submarkets, important products and national markets. Those analyses show you that pharmaceutical field’s most promising and lucrative segments. Published 21 March 2013 http://www.visiongain.com/Report/1009/Antibacterial-Drugs-World-Market-Prospects-2013-2023
    • Biobanking for Medicine: Technology and Market 2013-2023 Biobanks - what are their technological and commercial prospects? See what the future holds for biobanking in human medicine. Visiongain’s updated report gives you its revenue predictions to 2023. There you see sales data, technological trends, opportunities and financial prospects. Our study shows you the potential of technologies, products and services for that archiving of medical biosamples. In that work you see forecasted sales at overall world market, submarket and national level. Discover what’s likely to happen from 2013. Published 18 March 2013 http://www.visiongain.com/Report/1006/Biobanking-For-Medicine-Technology-And-Market-2013-2023 Dermatological Drugs: World Market Prospects 2013-2023 What’s the commercial outlook for treating skin disorders? visiongain’s updated report gives you forecasted revenues to 2023 and also explains R&D trends, outlooks and opportunities. Our study lets you assess sales data for the world market, therapeutic submarkets, products and national markets. Published 05 March 2013 http://www.visiongain.com/Report/993/Dermatological-Drugs-World-Market-Prospects-2013-2023
    • Antithrombotic Drugs: World Market 2013-2023 What does the future hold for treating conditions associated with thrombosis? Visiongain’s updated report gives you forecasted revenues to 2023, explaining R&D trends, outlooks and opportunities. Our study lets you assess sales data for the world market, submarkets, products and national markets. There you find that industry’s most promising and lucrative segments. Published 14 February 2013 http://www.visiongain.com/Report/982/Antithrombotic-Drugs-World-Market-2013-2023 Next-Generation Antibody Therapeutics Market 2013-2023 Where are therapeutic antibodies heading? Visiongain’s updated report gives you revenue predictions to 2023. There you see sales data, R&D trends, outlooks and opportunities. You find the potential of monoclonal antibodies (mAbs) and other immunotechnology. See forecasted sales at overall world market and submarket level. Also assess emerging trends and expected products. Many opportunities remain - you discover the areas to prosper. Published 05 February 2013 http://www.visiongain.com/Report/978/Next-Generation-Antibody-Therapeutics-Market-2013-2023
    • Pharma Clinical Trial Services: World Market 2013-2023 What’s the outlook for clinical research providers? Visiongain’s updated report gives you forecasted revenues to 2023. It explains trends, opportunities and commercial prospects. Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in clinical trial outsourcing, helping your research and analyses. Published 25 January 2013 http://www.visiongain.com/Report/973/Pharma-Clinical-Trial-Services-World-Market-2013-2023 Vaccine Manufacturing Technology and Services: World Market 2013-2023 What’s the outlook for producing vaccines? Visiongain’s updated report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for those technologies. Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in the production of vaccines, helping your research and analyses. There’s rising demand for those products and services. In particular, outsourced vaccine manufacturing will expand from 2013 to 2023, with growing revenues. Published 16 January 2013 http://www.visiongain.com/Report/966/Vaccine-Manufacturing-Technology-and-Services-WorldMarket-2013-2023
    • Epigenetic Therapies and Technologies: World Market Prospects 2013-2023 What does the future hold for epigenetic applications? Visiongain’s new report gives you revenue predictions to 2023 for those therapies, technologies and diagnostic products. There you find sales data, R&D trends, opportunities and commercial prospects. That analysis lets you assess forecasted sales at overall world market, submarket, product, regional and national level. You discover the potential of the industry and market for epigenetics, seeing where that field is heading. Published 09 January 2013 http://www.visiongain.com/Report/961/Epigenetic-Therapies-and-Technologies-World-MarketProspects-2013-2023 Parkinson’s Disease: World Drug Market 2013-2023 Where are treatments for Parkinson’s disease heading - technological and commercial outlooks? Visiongain’s updated report gives you forecasted revenues to 2023 and shows you R&D trends, opportunities and industry prospects. Emerging technologies hold promise. Our new study investigates developments, also letting you assess projected sales data at overall world market, submarket and national level. There you investigate the most promising areas in that industry and market segment for neurodegenerative disorders. Published 02 January 2013 http://www.visiongain.com/Report/957/Parkinson’s-Disease-World-Drug-Market-2013-2023
    • Small-Molecule Targeted Cancer Therapies: World Market 2013-2023 What does the future hold for small targeted agents to treat cancers? Visiongain’s updated report gives you revenue predictions to 2023. There you find sales data, R&D trends, opportunities and commercial prospects. You see the potential of those molecularly-targeted technologies and products. Our new analysis lets you assess forecasted sales at overall world market, product and national level. Discover how and why revenues can increase. Published 10 December 2012 http://www.visiongain.com/Report/948/Small-Molecule-Targeted-Cancer-Therapies-WorldMarket-2013-2023 Drug Discovery Outsourcing: World Market 2013-2023 See what the future holds for outsourcing early-stage drug development. There is rising demand for those services. Visiongain’s updated report gives you revenue predictions to 2023, showing you data, trends, opportunities and commercial prospects. Published 30 November 2012 http://www.visiongain.com/Report/945/Drug-Discovery-Outsourcing-World-Market-2013-2023
    • Generic Drugs: World Market 2013-2023 Where’s the generic drugs market heading? Visiongain’s updated report gives you revenue predictions to 2023. That new study lets you assess forecasted sales at overall world market and national level. You discover the potential of the generics market, seeing how, why and where it can grow. As pharma patents expire, much opportunity remains. Published 13 November 2012 http://www.visiongain.com/Report/932/Generic-Drugs-World-Market-2013-2023 World Pharmaceutical Contract Sales Market 2013-2023 Where are pharma contract sales organisations (CSOs) heading? Visiongain’s updated report gives you forecasted revenues to 2023 for that market and shows you trends, opportunities and industry prospects. For sales outsourcing our study lets you assess projected sales data at overall world market, submarket and national level. Published 06 November 2012 http://www.visiongain.com/Report/928/World-Pharmaceutical-Contract-Sales-Market-2013-2023
    • Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2013-2023 Where are treatments for macular degeneration (AMD) and diabetic retinopathy (DR) heading? Visiongain’s updated report gives you revenue predictions to 2023 for those eye disorders. This new study lets you assess forecasted sales at overall world market, submarket, product and national level. You discover the potential of that ophthalmic drug market, seeing how and why it can grow. Published 01 November 2012 http://www.visiongain.com/Report/924/Macular-Degeneration-(AMD)-and-Diabetic-Retinopathy-(DR)World-Drug-Market-2013-2023 Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2012-2022 Where is the pharma anti-counterfeiting industry heading? Visiongain’s updated report gives you forecasted revenues to 2022 and shows you trends, opportunities and industry prospects. Our study investigates technologies to tackle drug counterfeiters. It lets you assess projected sales data at overall world market, submarket and national level. There you investigate the most lucrative areas in that industry and market, seeing future outlooks. Published 26 October 2012 http://www.visiongain.com/Report/919/Pharmaceutical-Anti-counterfeiting-Technologies-MarketAnalysis-2012-2022
    • Pharma Leader Series: Top 20 Ophthalmic Drug Manufacturers 2012-2022 What does the future hold for top companies in the pharma ophthalmics industry? Visiongain’s new report shows you their prospects to 2022. You find financial data, trends, opportunities and revenue predictions. We analyse 29 leading companies for eye medicines, to help you see the future of that industry and market. Discover how sales of ocular drugs can increase. Published 16 October 2012 http://www.visiongain.com/Report/911/Pharma-Leader-Series-Top-20-Ophthalmic-DrugManufacturers-2012-2022 Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022 What does the future hold for top companies in the biosimilars industry? Visiongain’s new report shows you their prospects to 2022. You find financial data, trends, opportunities and revenue potentials. We analyse 25 leading developers and producers of biosimilars (follow-on biologics). Our analyses help you see the future of that industry and market. Published 01 October 2012 http://www.visiongain.com/Report/906/Pharma-Leader-Series-Top-25-Biosimilar-DrugManufacturers-2012-2022
    • World Multiple Myeloma Drug Treatment Market 2012-2022 See what the future holds for products to treat multiple myeloma. Visiongain’s updated report gives you revenue predictions to 2022. There you find data, trends, opportunities and commercial prospects. Our study lets you assess forecasted sales at overall world market, product and national level. Published 17 September 2012 http://www.visiongain.com/Report/895/World-Multiple-Myeloma-Drug-Treatment-Market-2012-2022 Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022 How are companies in the biological medicines (biologics) industry performing? Visiongain’s new report shows you organisations’ prospects to 2022. There you find financial data, trends, opportunities and commercial potentials. We assess 20 leading developers and producers of biological drugs and vaccines - our analyses help you see the future of the biopharma industry and market. Published 10 September 2012 http://www.visiongain.com/Report/889/Pharma-Leader-Series-Top-20-Biological-DrugManufacturers-2012-2022
    • Translational Regenerative Medicine: Market Prospects 2012-2022 See what the future holds for translational regenerative medicine. Visiongain’s updated report lets you assess forecasted sales at overall world market, submarket, product and regional level to 2022. How will four leading products - Apligraf, Dermagraft, DeNovo NT and Osteocel Plus - perform to 2022? You find business research and analysis with individual revenue forecasts and discussions. Published 31 August 2012 http://www.visiongain.com/Report/886/Translational-Regenerative-Medicine-Market-Prospects-2012-2022 Pharmaceutical Contract Manufacturing: World Market Outlook 2012-2022 How does the future look for pharmaceutical contract manufacturing? Visiongain’s report gives you sales predictions to 2022. You find data, trends, opportunities and commercial prospects. In our investigation you find revenue forecasting, growth rates and market shares. Also, you see qualitative analyses, including discussions of regulatory and commercial developments. Published 20 August 2012 http://www.visiongain.com/Report/880/Pharmaceutical-Contract-Manufacturing-World-MarketOutlook-2012-2022
    • Lyophilisation for Pharmaceuticals: Products and Services Market 2012-2022 What are the commercial prospects for pharmaceutical freeze drying? Visiongain’s report gives you revenue predictions to 2022 for equipment, services and applications. Our updated study lets you assess forecasted sales at overall world market, submarket, application and national level. Published 13 August 2012 http://www.visiongain.com/Report/877/Lyophilisation-for-Pharmaceuticals-Products-and-ServicesMarket-2012-2022 World Vaccines Market 2012-2022 Where is the vaccines sector heading? Visiongain’s report shows you forecasted revenues to 2022. You see data, trends, opportunities and industry prospects. Our new study investigates vaccines for human beings, letting you assess projected sales at overall world market, submarket, product and national level. Many segments hold growth potential. Published 25 July 2012 http://www.visiongain.com/Report/859/World-Vaccines-Market-2012-2022
    • Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022 How are leading companies in the antibacterial drugs market performing? Visiongain’s new report gives you data, analyses and revenue predictions for antibacterial manufacturers. See how top companies worldwide are performing and where they are heading. You assess their technologies, products and commercial prospects to 2022. Published 21 June 2012 http://www.visiongain.com/Report/841/Pharma-Leader-Series-Top-20-Antibacterial-DrugManufacturers-2012-2022 World OTC Pharmaceutical Market 2012-2022 What does the future hold for OTC medicines? Visiongain’s report shows you potential revenues to 2022, assessing data, trends, opportunities and prospects there. This new study investigates OTC (over-the-counter) pharmaceuticals: medicines sold without prescriptions. It lets you assess projected sales at world market, therapeutic submarket, product and national level to 2022. Published 06 June 2012 http://www.visiongain.com/Report/833/World-OTC-Pharmaceutical-Market-2012-2022
    • Neuroprotective Products: World Market Prospects 2012-2022 What are the commercial prospects for neuroprotective treatments? Visiongain’s new report shows you potential revenues and trends to 2022, discussing data, opportunities and outlooks. Many neuroprotective products are in development. Our study lets you assess projected sales at overall world market, therapeutic submarket and product level to 2022. In particular, how will 11 products - including Rasagiline, Minocycline, Memantine and NeuroSTAT - perform to 2022? Published 10 May 2012 http://www.visiongain.com/Report/819/Neuroprotective-Products-World-Market-Prospects-2012-2022 Smoking Cessation Drugs: World Market Prospects 2012-2022 What are the commercial prospects for anti-smoking treatments? Visiongain’s report shows you potential revenues and trends to 2022, discussing data, opportunities and prospects. Our investigation gives you business research and analysis with sales forecasts. It lets you assess forecasted sales at world market, submarket, product and national level to 2022. You find analysis of prescription (Rx) and over-the-counter (OTC) therapies for smoking. How will leading products - including Nicorette, Nicotinell and Champix/Chantix - perform from 2012? Published 16 April 2012 http://www.visiongain.com/Report/800/Smoking-Cessation-Drugs-World-Market-Prospects-2012-2022
    • Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022 How are companies in the pre-filled syringe industry performing? Visiongain’s report gives you data, analyses and discussions for producers of those drug delivery devices. That new study lets you assess prominent companies in the pre-filled (ready-to-fill) syringe industry and market from 2012 to 2022. Published 15 February 2012 http://www.visiongain.com/Report/765/Pharma-Leader-Series-Top-Pre-Filled-Injection-DeviceManufacturers-2012-2022 Multiple Sclerosis Treatment: World Drug Market 2012-2022 What are the commercial prospects for multiple sclerosis treatment? Discover revenue predictions for multiple sclerosis (MS) treatments at world market, product and national levels to 2022. How will the drugs Copaxone, Avonex, Rebif, Betaseron/Betaferon, Tysabri, Extavia and Gilenya perform to 2022? Published 23 November 2011 http://www.visiongain.com/Report/723/Multiple-Sclerosis-Treatment-World-Drug-Market-2012-2022
    • Next-Generation Antibody Therapies: Pipeline and Market 2011-2021 What are the prospects for emerging antibody technologies? Visiongain’s report shows you potential revenues to 2021, discussing R&D trends and opportunities. A new generation of therapeutic antibody is coming. Discover revenue predictions for emerging antibody technologies at total world and submarket levels to 2021. Published 08 November 2011 http://www.visiongain.com/Report/712/Next-Generation-Antibody-Therapies-Pipeline-andMarket-2011-2021 World Pharma Contract Sales Organisation (CSO) Market 2011-2021 How will the pharma contract sales market perform from 2011? Visiongain’s report shows you potential revenues and trends to 2021, discussing opportunities and prospects. Our report gives you forecasts to 2021 for the world market and leading countries. Outsourced pharma sales activities will expand from 2011 to 2021. See how emerging technologies are changing drug promotion and sales, and how service providers contribute value to pharmaceutical sales operations. Published 30 September 2011 http://www.visiongain.com/Report/691/World-Pharma-Contract-Sales-Organisation-(CSO)Market-2011-2021
    • Therapeutic Monoclonal Antibodies: World Market 2011-2021 How will the market for monoclonal antibody (mAb) therapies perform from 2011? How will competition affect the mAb industry and market? Which national markets have the greatest potential for growth? Discover mAb treatment revenues at total world, submarket, product and national levels. The monoclonal antibody drug market has potential to expand. See how treatments such as Avastin, Herceptin, MabThera, Remicade, Humira, Tysabri and Lucentis can perform to 2021. Published 19 September 2011 http://www.visiongain.com/Report/685/Therapeutic-Monoclonal-Antibodies-World-Market-2011-2021 Pharmacovigilance and Related Developments 2011-2021 What does the future hold for pharmacovigilance? Visiongain’s new report shows you prospects to 2021, discussing opportunities and developments. Find data you need. Assess events, opportunities and activities shaping pharmacovigilance to 2021: regulations, technologies and services. How will changes affect pharmacovigilance? What are drug producers and service providers doing? What regulations and technologies influence that field? Published 22 August 2011 http://www.visiongain.com/Report/674/Pharmacovigilance-and-Related-Developments-2011-2021
    • Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 What are the commercial prospects for lyophilisation technology? Our new report shows you potential revenues to 2021. Our report covers lyophilisation (cryodesiccation or freeze drying) in pharmaceutical applications: technologies, products and services. You will assess events, opportunities and activities shaping the lyophilisation industry and market from 2011 to 2021. Published 27 June 2011 http://www.visiongain.com/Report/633/Lyophilisation-for-Pharmaceuticals-Technology-and-ServicesMarket-2011-2021 Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021 What are the commercial prospects for the pharmacological treatment of acute coronary syndrome? Our new report shows you its revenue potential from 2011 to 2021. Our study covers ACS treatments, including those for unstable angina (UA) and acute myocardial infarction (AMI). You will see commercial prospects for platelet aggregation inhibitors, anticoagulant treatments, fibrinolytic agents and their subgroups to 2021. Published 06 May 2011 http://www.visiongain.com/Report/610/Acute-Coronary-Syndrome-(ACS)-Drug-Market-Prospects-2011-2021
    • Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021 How will the genomic sequencing market develop this decade? This report covers technology to support genomics, with an emphasis on pharma R&D. Our new study shows you revenue prospects for genomic technologies at total world, submarket, company and national levels to 2021. Third-generation sequencing platforms can increase throughput and lower costs. Published 03 May 2011 http://www.visiongain.com/Report/609/Genomic-Sequencing-Technologies-for-Medicine-MarketProspects-2011-2021 Pharmaceutical Wholesale and Distribution Industry: World Outlook 2011-2021 How will the pharma wholesale and distribution industry perform from 2011 onwards? What effects will healthcare budget cuts have on pharmaceutical wholesalers? Which national markets will provide the best opportunities from 2011 to 2021? How common will direct-to-pharmacy distribution become? Our work provides answers you need. Published 01 April 2011 http://www.visiongain.com/Report/595/Pharmaceutical-Wholesale-and-Distribution-Industry-WorldOutlook-2011-2021
    • RNAi for Therapeutic Applications Market Prospects 2011-2021 How will the RNA interference (RNAi) therapies market develop this decade? Our new report shows you that emerging market’s revenue potential from 2011 to 2021. Our new study shows you revenue prospects for RNAi technologies at total world, geographical and product levels. We discuss RNAi applications for cancer, respiratory disorders, eye disorders and other diseases. Published 29 March 2011 http://www.visiongain.com/Report/590/RNAi-for-Therapeutic-Applications-Market-Prospects-2011-2021 World Diabetes Drug Market 2011-2021 Where will revenue growth occur in the diabetes treatment market? Our new report shows you the potential that drug market offers from 2011 to 2021, explaining the opportunities there. You will discover revenue prospects for diabetes treatments at total world, sub-market, product and national levels. We show potential revenues for human insulins and analogues, as well as other diabetes treatments. You will discover revenue prospects for Novo Nordisk, GSK, Takeda, sanofi-aventis, Eli Lilly, Merck and other companies from 2011 onwards. Published 11 March 2011 http://www.visiongain.com/Report/585/World-Diabetes-Drug-Market-2011-2021
    • Statins: World Market Outlook 2011-2021 What does the future hold for the statins industry and market? Our new report shows how the patent expiry of Lipitor and others will affect statin drug revenues from 2011 onwards. In 2009 the world statins market generated over $27bn in revenues. We show the organisations, products and activities that will shape the statins industry and market this decade. Published 03 March 2011 http://www.visiongain.com/Report/581/Statins-World-Market-Outlook-2011-2021 World Anti-Obesity Drug Market 2011-2021 What will this decade hold for the challenged anti-obesity drug industry and market? Our new report gives you revenue forecasts at world, product and national level. How will the regulatory and marketing difficulties facing anti-obesity drugs affect companies and their revenues? In our report you will see prospects for obesity drug research, development, launches and marketing from 2011 onwards. Published 21 February 2011 http://www.visiongain.com/Report/575/World-Anti-Obesity-Drug-Market-2011-2021
    • World Influenza Vaccines Market 2011-2021 Are you looking for influenza vaccine market data - answers to benefit your work? Our new report shows you revenue prospects for the manufacture and sale of influenza vaccines from 2009 to 2021. Published 07 February 2011 http://www.visiongain.com/Report/572/World-Influenza-Vaccines-Market-2011-2021 SOON TO BE PUBLISHED TOPICS Smoking Cessation Drugs: World Market Prospects 2013-2023 World Vaccines Market 2013-2023 Clinical Trial Logistics: World Market 2013-2023 World Multiple Myeloma Drug Treatment Market 2013-2023 Medical Devices Industry and Market Prospects 2013-2023 World OTC Pharmaceutical Market 2013-2023
    • ABOUT VISIONGAIN PHARMA REPORTS In our analytical reports we cover a wide range of industries and markets in healthcare. We show you future prospects for many commercial areas: • Novel branded pharmaceuticals – therapeutic applications and drug classes • Biopharmaceuticals (biologics) and healthcare biotechnology, including drug delivery and other technologies • Generic drugs, the pharma supply chain and over-the-counter (OTC) medicines • Outsourced services – clinical trials, pharma manufacturing and other roles • Diagnostic tests and instruments • Medical devices – implants and other products. There you find revenue forecasts. Our reports analyse and explain commercial prospects at overall world, submarket, national and product level, suiting the topics. That way, you assess opportunities and commercial potentials for healthcare industries and markets. We pack our reports with information to help your work and save you time: • Access to present and predicted trends, harnessing years of analytical experience and knowledge • Data and discussions – including our 10-year revenue forecasts – for your research, analyses and decision making • Tables, charts and lists to benefit your reports, proposals and presentations. In our investigations you find revenue forecasting, growth rates and market shares. You see qualitative analyses (SWOT and STEP), R&D and commercial news too. We also show you interviews with authorities. You see opinions from our surveys. The reports harness company and industry literature, outside experts, surveys, public health data and policy documents. You find discussions of technological, commercial and economic issues, with emphasis on competing organisations. Discover their prospects, including reviews of companies.
    • In addition to covering worldwide markets, our analysts show you revenue forecasts and other information for leading national markets. Examples include the US, Japan, Germany, France, the UK, Spain, Italy (EU5), India and China. Our studies give you analysis from primary and secondary research. You receive information found only in our work – quantitative and qualitative analyses with independent predictions. Many commercial opportunities exist. We show you where these are and explain their significance and potential from this decade onwards. You find knowledge to help you stay ahead. We look forward to meeting your business intelligence needs for healthcare. Please let us help your work now. To see all visiongain pharma reports please visit http://www.visiongain.com/Sector/8/Pharma MORE INFORMATION Contact Ediz Ibrahim ediz.ibrahim@visiongainglobal.com +44 (0) 20 7336 9976
    • VISIONGAIN LICENCES Single User License This license allows for use of a report by one named person. This person may use the report, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons. Unless a Departmental License, a Site License or a Global Site License is purchased, a Single User License must be purchased for every person that wishes to use the report within the same enterprise. Customers who infringe these licence terms are liable for a Global Site licence fee. Departmental Licenses This license allows for use of a report by five people within the same enterprise location. Each of these people may use the report, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons. Customers who infringe these licence terms are liable for a Global Site licence fee. Site License This license allows for use of a report by an unlimited number of people within the same enterprise location. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any person or persons outside of the enterprise location. Customers who infringe these licence terms are liable for a Global Site licence fee. Global License This license allows for use of a report by an unlimited number of people within the same enterprise worldwide. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons outside of the enterprise.
    • PHARMA REPORT SALES ORDER FORM Fax back to: +44 (0) 207 549 9930 Report licenses (please tick box) Yes, I want to purchase the report below Report title................................................................................ ������������������������������������������������������������������������������������������������ ������������������������������������������������������������������������������������������������ Single user £1499 or £1549 or £1699 (plus 20% VAT) Departmental (five users) £2999 (plus 20% VAT) Site (one location) £4999 (plus 20% VAT) Global £6999 (plus 20% VAT) Contact Information First Name ..................................................................................... Last Name ................................................................................... Job Title .............................................................................................................................................................................................. Company Name.................................................................................................................................................................................. Address .............................................................................................................................................................................................. City............................................................. Postcode ..................................................... Country...................................................... Tel ................................................................................................. Fax .............................................................................................. E-mail ................................................................................................................................................................................................. End-user Email(s) – If different from above ....................................................................................................................................... ........................................................................................................................................................................................................... EU members are VAT exempt if VAT number is provided. EEC VAT Number (EU Only)............................................. Signature...................................................................................... Payment Information (please select) Paying by Credit Card Please select as appropriate Visa MasterCard American Express Card No Expiry Date Security No Issue No Paying by Invoice (Bank transfer or Cheque) Visiongain Ltd A/C: Visiongain Ltd Barclays Bank PLC Sort Code: 20-71-64 Piccadilly Branch Account No: 6038 7118 48 Regent Street Swift Code: BARC GB22 London, W1B 5RA, UK IBAN: GB80 BARC 20716460387118 VISIONGAIN LTD - 230 City Road, London, EC1V 2QY, UK - Registration Number: 3626739 Other CC